NCT07174583
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07174583
Title A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors IDEAYA Biosciences
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE NOT_YET_RECRUITING Denver Colorado 80218 United States Details
The University of Chicago Medical Center - Duchossois Center for Advanced Medicine NOT_YET_RECRUITING Chicago Illinois 60637 United States Details
The Cancer and Hematology Centers RECRUITING Grand Rapids Michigan 49546 United States Details
Columbia University Medical Center - Herbert Irving Pavilion NOT_YET_RECRUITING New York New York 10032 United States Details
Sidney Kimmel Cancer Center at Thomas Jefferson University NOT_YET_RECRUITING Philadelphia Pennsylvania 19107 United States Details
Sarah Cannon Research Institute - Oncology Partners NOT_YET_RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson NOT_YET_RECRUITING Houston Texas 77030 United States Details
Next Oncology Dallas RECRUITING Irving Texas 75039 United States Details
NEXT Oncology Virginia RECRUITING Fairfax Virginia 22031 United States Details
Swedish Cancer Institute NOT_YET_RECRUITING Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field